Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Alighieri who wrote (211146)	11/8/2004 3:12:29 PM
From: i-node	Read Replies (1) \| Respond to of 1570684

>> of course biddind and re-importation results in lower costs to consumers and lower profits to drug companies. Good enough. So you know the rest of my position. That is, if you reduce drug company profits they aren't going to risk big dollars to develop new drugs that don't have the potential to generate big dollars. THIS is capitalism. If you squeeze the drug companies profits, you also squeeze their willingness to spend on R&D. Then, they get it on the other end, as well, with unlimited exposure like with VIOXX. You can't have it both ways. If you want the best drugs available, you have to be willing to pay the people who take the risks in developing them. But you knew that, didn't you?